Neutralizing antibodies against sequential autologous human immunodeficiency virus type 1 isolates after seroconversion.
about
Longitudinal study of primary HIV-1 isolates in drug-naïve individuals reveals the emergence of variants sensitive to anti-HIV-1 monoclonal antibodiesEvolutionary dynamics of HIV-induced subversion of the immune response.Evolution of the human immunodeficiency virus type 1 envelope during infection reveals molecular corollaries of specificity for coreceptor utilization and AIDS pathogenesis.Neutralizing antibodies against autologous human immunodeficiency virus Type 1 isolates in patients with increasing CD4 cell counts despite incomplete virus suppression during antiretroviral treatment.Neutralization patterns and evolution of sequential HIV type 1 envelope sequences in HIV type 1 subtype B-infected drug-naive individuals.Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1Mechanism of human immunodeficiency virus type 1 resistance to monoclonal antibody B12 that effectively targets the site of CD4 attachment.Host factors in the pathogenesis of HIV disease.Addition of a single gp120 glycan confers increased binding to dendritic cell-specific ICAM-3-grabbing nonintegrin and neutralization escape to human immunodeficiency virus type 1.Autologous and heterologous neutralization analyses of primary feline immunodeficiency virus isolates.Development of a neutralizing antibody response during acute primary human immunodeficiency virus type 1 infection and the emergence of antigenic variants.Evidence for similar recognition of the conserved neutralization epitopes of human immunodeficiency virus type 1 envelope gp120 in humans and macaques.Reversal of human immunodeficiency virus type 1 IIIB to a neutralization-resistant phenotype in an accidentally infected laboratory worker with a progressive clinical course.Autologous and heterologous neutralizing antibody responses following initial seroconversion in human immunodeficiency virus type 1-infected individuals.The effect of different immune responses on the evolution of virulent CXCR4-tropic HIV.
P2860
Q28477253-26376D07-9D74-4AFF-8815-45B7B909E38AQ33683341-82FE3E95-DCE6-416A-B048-18CFA76E6D7BQ33813025-68C5B2A3-0592-41C6-A3B8-61FD6BCE0D90Q33999316-9FA26754-9C1D-4945-B996-28E7A6A8BB2CQ34085098-C7749E8B-9510-49EF-ADFA-F7EF2582BD54Q35880498-F1C7205E-7CAE-4CF5-9877-EBE8A9AF2C32Q37410770-DC82CD92-F4AD-4CB2-BE93-512C91F6AF4AQ38949921-5E172FE6-0E3A-4059-B857-E464C3392B5AQ39193318-16BE236D-1EC5-4F08-A2F2-C883D88E4417Q39577849-2C2395C2-9837-46D0-B71B-0D846EC573C7Q39582046-9CDDFA99-124A-4806-8312-FD3D68A24052Q39604142-A6336095-3DD8-4707-897A-419D6F9A5994Q39605628-D2E84112-0D58-4732-B3F0-7A88EB19E4D7Q39879382-269BC40E-FE27-4A6B-A17A-454FBEAD15A6Q52228583-FE4EDDA6-479A-4594-9A3B-DAB6AA5CE652
P2860
Neutralizing antibodies against sequential autologous human immunodeficiency virus type 1 isolates after seroconversion.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Neutralizing antibodies agains ...... isolates after seroconversion.
@en
Neutralizing antibodies agains ...... isolates after seroconversion.
@nl
type
label
Neutralizing antibodies agains ...... isolates after seroconversion.
@en
Neutralizing antibodies agains ...... isolates after seroconversion.
@nl
prefLabel
Neutralizing antibodies agains ...... isolates after seroconversion.
@en
Neutralizing antibodies agains ...... isolates after seroconversion.
@nl
P2093
P356
P1476
Neutralizing antibodies agains ...... isolates after seroconversion.
@en
P2093
P304
P356
10.1093/INFDIS/170.5.1141
P407
P577
1994-11-01T00:00:00Z